RISalud
Institutional Health Repository of Andalucía
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/804| Title: | Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study |
| Authors: | Carabante-Ocón, F Saez-Lara, E Burgos-Garcia, L Villar-Chamorro, E Casaus-Hazañas, A Luna, S Martínez, C |
| metadata.dc.contributor.authoraffiliation: | [Carabante-Ocón,F; Saez-Lara, E; Burgos-Garcia, L; Villar-Chamorro, E; Casaus-Hazañas, A; Luna, S; Martínez, C] Unidad de Mama, Hospital Carlos Haya, Málaga, Spain. |
| Keywords: | trastuzumab;her2-positive;chemotherapies;MBC;neoplasias de la mama;Retratamiento |
| metadata.dc.subject.mesh: | Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Retreatment |
| Issue Date: | 19-Jun-2007 |
| Publisher: | BioMed Central |
| Citation: | Carabante-Ocón F, Saez-Lara E, Burgos-Garcia L, Villar-Chamorro E, Casaus-Hazañas A. Luna S, et al. Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study. Breast Cancer Research. 2007 Jun;9 Supplement 1:s17-8 |
| Abstract: | Objective: To study the benefit of trastuzumab in monotherapy or combined with different chemotherapeutic agents in the treatment for Her2+ metastatic breast cancer (MBC) patients after progression on prior trastuzumab therapy. |
| URI: | http://hdl.handle.net/10668/804 |
| metadata.dc.relation.publisherversion: | http://breast-cancer-research.com/supplements/9/S1/all |
| metadata.dc.identifier.doi: | 10.1186/bcr1708 |
| ISSN: | 1465-5411 (Print) 1465-542X (Online) |
| Appears in Collections: | 01- Artículos - Hospital Regional de Málaga |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| CarabantesOcon_RetreatmentWithTrastuzumab.pdf | Poster | 52,4 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License
